SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-18-001706
Filing Date
2018-02-13
Accepted
2018-02-13 17:02:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G sc13g0218a3cfwoodford_thera.htm SC 13G/A 80504
  Complete submission text file 0001213900-18-001706.txt   82222
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 18604574
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 0044 845922 0044
CF Woodford Equity Income Fund (Filed by) CIK: 0001637243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A